Rosuvastatin stabilizes atherosclerotic plaques by reducing CD40L overexpression-induced downregulation of P4Hα1 in ApoE-/- mice.

Abstract

Background Cluster of differentiation 40 ligand (CD40L) and rosuvastatin (RSV) affect atherosclerotic plaque stability, but little is known about their roles in extracellular matrix (ECM) production. We investigated the effects of CD40L and RSV on pre-existing advanced plaques. Methods and results Pre-existing advanced plaques were induced in apolipoprotein E-knockout (ApoE-/-) mice by the surgical placement of carotid constrictive silastic collars. Two weeks after surgery, mice were divided into the following treatment groups: control, empty adenovirus, CD40L adenovirus, CD40L adenovirus + RSV, and RSV. Mice received adenovirus via two tail-vein injections (2 × 109 pfu each) and/or RSV via intragastric administration (5 mg/kg; daily for 4 weeks). Mice in the CD40L adenovirus group exhibited increased plaque disruption rates, increased relative plaque macrophage and lipid content, reduced plaque collagen content, and increased local inflammation compared to the other treatment groups, but no significant differences in plaque area were observed among the groups. Notably, in the atherosclerotic plaques of the CD40L adenovirus group, both the mRNA and protein expression of prolyl-4-hydroxylase alpha 1 (P4Hα1) was significantly decreased, leading to a consequent decrease in the protein expression of collagen types I and III. Treatment with RSV decreased the serum levels of CD40L in a lipid-independent fashion and attenuated the effects of CD40L overexpression, particularly with respect to P4Hα1 downregulation. Conclusions CD40L destabilized advanced plaques in the carotid arteries of ApoE-/- mice, in part by decreasing P4Hα1 expression, and consequently collagen expression. These destabilizing effects were attenuated by RSV.

• Authors: Xiao-Lin Wang, Wei Sun, Yuan-Li Zhou, Li Li
• Journal: The international journal of biochemistry & cell biology (Int J Biochem Cell Biol) Vol. 105 Pg. 70-77 (12 2018) ISSN: 1878-5875 [Electronic] Netherlands
• PMID: 30336263 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2018 Elsevier Ltd. All rights reserved.

Chemical References

• Apolipoproteins E
• Hydroxymethylglutaryl-CoA Reductase Inhibitors
• Lipids
• RNA, Messenger
• CD40 Ligand
• Rosuvastatin Calcium
• Procollagen-Proline Dioxygenase

Topics

• Animals
• Apolipoproteins E (deficiency, genetics)
• CD40 Ligand (blood, genetics)
• Disease Models, Animal
• Down-Regulation (drug effects)
• Hydroxymethylglutaryl-CoA Reductase Inhibitors (pharmacology)
• Lipids (blood)
• Male
• Mice
• Mice, Knockout, ApoE
• Plaque, Atherosclerotic (drug therapy, genetics, pathology)
• Procollagen-Proline Dioxygenase (genetics, metabolism)
• RNA, Messenger (genetics, metabolism)
• Rosuvastatin Calcium (pharmacology)